CD44 and cancer: Our previous results demonstrated thatthe CD44 receptor mediates endocytosis of these HA-coated NPs in HCT116p53–/– cells.16 Due to their versatility, double-coated NPs have been tested inother CD44-positive cancer models for the targeted delivery of chemotherapeuticcombinations.42,43